Changjiang Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 90.8% in First Half of 2022

Changjiang Pharmaceutical Group Co.,Ltd. (长江医药控股股份有限公司) (300391.SZ) reported a net profit of 14.6 million yuan in the first half of 2022, down 90.8% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, down 23.6% year-on-year.

At the end of the reporting period, it had 4.3 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 62.1%.